Bioject Medical Technologies secures $1.2 million Series G Preferred Stock financing - MarketLine Financial Deals

Bioject Medical Technologies secures $1.2 million Series G Preferred Stock financing

Bioject Medical Technologies secures $1.2 million Series G Preferred Stock financing - MarketLine Financial Deals
Bioject Medical Technologies secures $1.2 million Series G Preferred Stock financing
Published Dec 18, 2009
2 pages — Published Dec 18, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Bioject Medical Technologies, Inc., a US-based developer and manufacturer of needle-free injection therapy systems, has secured Series G preferred stock financing from each of Life Sciences Opportunities Fund II, L.P., Life Sciences Opportunities Fund (Institutional) II, L.P., and Edward Flynn.

  
Source:
Document ID
MA16375_100106
Country
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Bioject Medical Technologies secures $1.2 million Series G Preferred Stock financing" Dec 18, 2009. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Bioject-Medical-Technologies-secures-1-2-million-Series-G-Preferred-Stock-financing-2052-21531>
  
APA:
MarketLine Financial Deals. (2009). Bioject Medical Technologies secures $1.2 million Series G Preferred Stock financing Dec 18, 2009. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Bioject-Medical-Technologies-secures-1-2-million-Series-G-Preferred-Stock-financing-2052-21531>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.